G
$ Value
$0
Shares
25,000
Price
$0
Filed
Jun 24
Insider
Name
Thomas John
Title
—
CIK
0001939103
Roles
Director
Transaction Details
Transaction Date
2025-06-06
Code
G
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
480,501
Filing Info
Thomas John's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | GNLX | ▼ | $29K |
| 2025-12-01 | GNLX | ▼ | $50K |
| 2025-08-27 | GNLX | A | $0 |
| 2025-08-27 | GNLX | A | $0 |
| 2025-06-06 | GNLX | G | $0 |
Other Insiders at GNLX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Yu Yong / Cappello Joseph
SVP, Clinical Development
|
— | $2K | 2026-03-24 |
|
Zindrick Thomas
President and CEO
|
— | $9K | 2026-03-24 |
| Thomas John | — | $29K | 2026-03-02 |
|
Smalling Ralph
Head of Regulatory
|
— | $1K | 2026-03-25 |